Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
D000077713:17 alpha-Hydroxyprogesterone Caproate; D000230:Adenocarcinoma / Q000401:mortality / Q000628:therapy*; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D007044:Hysterectomy; D011182:Postoperative Care; D011300:Preoperative Care; D045167:Progesterone Congeners / Q000627:therapeutic use; D011882:Radiotherapy, High-Energy; D014594:Uterine Neoplasms / Q000401:mortality / Q000628:therapy*
D006908:Hydroxyprogesterones; D045167:Progesterone Congeners; D000077713:17 alpha-Hydroxyprogesterone Caproate